JP2000236877A - 精度管理用物質 - Google Patents
精度管理用物質Info
- Publication number
- JP2000236877A JP2000236877A JP11093232A JP9323299A JP2000236877A JP 2000236877 A JP2000236877 A JP 2000236877A JP 11093232 A JP11093232 A JP 11093232A JP 9323299 A JP9323299 A JP 9323299A JP 2000236877 A JP2000236877 A JP 2000236877A
- Authority
- JP
- Japan
- Prior art keywords
- quality control
- substance
- prepared
- human
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 42
- 238000003908 quality control method Methods 0.000 title claims abstract description 22
- 230000006798 recombination Effects 0.000 claims abstract description 6
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 5
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 5
- 210000002966 serum Anatomy 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 238000012239 gene modification Methods 0.000 claims 1
- 230000005017 genetic modification Effects 0.000 claims 1
- 235000013617 genetically modified food Nutrition 0.000 claims 1
- 239000012086 standard solution Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 3
- 108010082126 Alanine transaminase Proteins 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 3
- 108010071390 Serum Albumin Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 102000003914 Cholinesterases Human genes 0.000 description 2
- 108090000322 Cholinesterases Proteins 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 2
- 108010042126 Creatine kinase Proteins 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- -1 Tris buffer Chemical compound 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940048961 cholinesterase Drugs 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- 101710134031 CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000012406 Carcinoembryonic Antigen Human genes 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- 102100023441 Centromere protein J Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101710199286 Cytosol aminopeptidase Proteins 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 101710197780 E3 ubiquitin-protein ligase LAP Proteins 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 108010022203 Leucine transaminase Proteins 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 101710204480 Lysosomal acid phosphatase Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 101710089118 Probable cytosol aminopeptidase Proteins 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11093232A JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000236877A true JP2000236877A (ja) | 2000-09-05 |
| JP2000236877A5 JP2000236877A5 (enExample) | 2006-03-09 |
Family
ID=14076805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11093232A Pending JP2000236877A (ja) | 1999-02-23 | 1999-02-23 | 精度管理用物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000236877A (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002052278A1 (en) * | 2000-12-22 | 2002-07-04 | International Reagents Corporation | Clinical examination precision guarantee system |
| WO2003066681A1 (en) * | 2002-02-05 | 2003-08-14 | Delta Biotechnology Limited | Stabilization of protein preparations |
| JP2007271641A (ja) * | 2007-07-26 | 2007-10-18 | Sysmex Corp | 精度管理方法 |
| JP2007279059A (ja) * | 2007-06-18 | 2007-10-25 | Sysmex Corp | 臨床検査精度管理システム |
| JP2007286071A (ja) * | 2007-07-26 | 2007-11-01 | Sysmex Corp | 精度管理方法 |
| JP2009020126A (ja) * | 2008-10-28 | 2009-01-29 | Sysmex Corp | 精度管理方法 |
| JP2012532312A (ja) * | 2009-06-30 | 2012-12-13 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気センサ装置、このような装置の作動方法及びサンプル |
| CN101809161B (zh) * | 2007-08-07 | 2014-03-12 | 中外制药株式会社 | 异种蛋白的制备方法 |
| CN113049839A (zh) * | 2019-12-27 | 2021-06-29 | 桂林英美特生物技术研究所 | 一种稳定的肝功能类复合质控品 |
-
1999
- 1999-02-23 JP JP11093232A patent/JP2000236877A/ja active Pending
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002052278A1 (en) * | 2000-12-22 | 2002-07-04 | International Reagents Corporation | Clinical examination precision guarantee system |
| WO2003066681A1 (en) * | 2002-02-05 | 2003-08-14 | Delta Biotechnology Limited | Stabilization of protein preparations |
| JP2007279059A (ja) * | 2007-06-18 | 2007-10-25 | Sysmex Corp | 臨床検査精度管理システム |
| JP2007271641A (ja) * | 2007-07-26 | 2007-10-18 | Sysmex Corp | 精度管理方法 |
| JP2007286071A (ja) * | 2007-07-26 | 2007-11-01 | Sysmex Corp | 精度管理方法 |
| CN101809161B (zh) * | 2007-08-07 | 2014-03-12 | 中外制药株式会社 | 异种蛋白的制备方法 |
| JP2009020126A (ja) * | 2008-10-28 | 2009-01-29 | Sysmex Corp | 精度管理方法 |
| JP2012532312A (ja) * | 2009-06-30 | 2012-12-13 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気センサ装置、このような装置の作動方法及びサンプル |
| US9557328B2 (en) | 2009-06-30 | 2017-01-31 | Koninklijke Philips N.V. | Magnetic sensor device, method of operating such a device and sample |
| CN113049839A (zh) * | 2019-12-27 | 2021-06-29 | 桂林英美特生物技术研究所 | 一种稳定的肝功能类复合质控品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5583200A (en) | Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays | |
| EP2758782B1 (en) | Customized quality controls for analytical assays | |
| JP2008544977A (ja) | タンパク質を含む安定水系 | |
| JP2000236877A (ja) | 精度管理用物質 | |
| JPH0650999B2 (ja) | 血液凝固因子安定化法 | |
| JP4106111B2 (ja) | イムノアッセイ用較正／対照用配合物 | |
| CN111060692A (zh) | 一种免疫球蛋白g1的检测试剂盒及其制备方法 | |
| JPH0222909B2 (enExample) | ||
| Perrin et al. | Competitive binding of two drugs for a single binding site on albumin: a circular dichroic study | |
| US20040033529A1 (en) | Stabilized composition of troponin for immunoassays and method of preparation of such a stabilized composition | |
| JPS6176423A (ja) | モノクロナ−ル抗体の安定化 | |
| JP4261665B2 (ja) | 溶液中のヒトヘモグロビンの安定化方法および安定化溶液 | |
| JP2004108850A (ja) | 蛋白質の安定化方法 | |
| US20030125234A1 (en) | Alteration of protein stability | |
| JPH10282105A (ja) | 血清アミロイドａ測定用キャリブレーターの製造方法 | |
| JP4033534B2 (ja) | ヒトヘモグロビンの安定化方法 | |
| JP4546596B2 (ja) | ステロールエステルの添加による生物学的液体の安定化 | |
| JP3573330B2 (ja) | 安定化された抗原含有水溶液 | |
| JP2542787B2 (ja) | チロキシン（ｔ４）またはトリヨ−ドチロニン（ｔ３）の測定法およびそのための標準溶液 | |
| JP4273534B2 (ja) | ヘム蛋白質の安定化剤及び安定化方法 | |
| JP2007212343A (ja) | 抗原の測定法およびそれに用いるキット | |
| JPH0961431A (ja) | ヒトヘモグロビンの安定化試薬及び安定化方法 | |
| JP2000131323A (ja) | 調整管理血清 | |
| JPH11125635A (ja) | 感作金属コロイド含有安定化凍結乾燥物及びその製造方法 | |
| JP3365693B2 (ja) | 長期間にわたり安定で澄明な血清の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050928 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060123 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060123 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20071102 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081029 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090128 |